Certara shares tumble 12% on weak guidance despite revenue beat
Corroborated by 2 sources from 2 publishers
globalbusiness2h ago
TL;DR
Certara shares tumble 12% on weak guidance despite revenue beat Key Points - Interested in Certara, Inc. Here are five stocks we like better. - - The company completed the divestiture of its regulatory and medical writing business to Veristat and is reorganizing around two priorities: MID3 and ACE.